Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Anaesth ; 121(3): 581-587, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30115256

ABSTRACT

BACKGROUND: Colloid solutions have been associated with kidney dysfunction in septic animals and humans. The present study investigated the influence of resuscitation with human albumin (HA) 5%, hydroxyethyl starch (HES) 130/0.4 6%, and balanced crystalloids on ultrastructural kidney damage, kidney function, and survival in a model of ovine septic shock. METHODS: After induction of peritoneal septic shock, animals were randomised to one of the following groups: (1) HA 5%, (2) HES 130/0.4 6%, (3) balanced crystalloid, and (4) control (each n=10). Causal therapy included re-laparotomy, peritoneal lavage, and antimicrobial therapy. Sequential kidney biopsies were obtained for the assessment of the electron microscopic tubular injury (EMTI) score. RESULTS: Serum creatinine and urea were highest in the control group, and there were no differences between the intervention groups. Cumulative diuresis was significantly higher in the HA group [1.0 ml kg-1 h-1 (0.6; 1.2)] compared with control [0.7 ml kg-1 h-1 (0.6; 0.9), P<0.05]. Creatinine clearance was highest in the HA and crystalloid groups. Ultrastructural kidney damage was highest in the control group [EMTI score 7.8 (6.7; 9.0)] without differences between intervention groups. Survival was 100% in the colloid groups vs 90% (crystalloid) and 60% (control, all P<0.05). CONCLUSION: In an ovine model of septic shock, kidney function and cumulative diuresis were preserved in the 5% albumin and crystalloid resuscitation groups, whereas HES 130/0.4 6% resulted in diminished creatinine clearance. Differences in kidney function between resuscitation fluids could not be explained by differences in ultrastructural kidney damage. CLINICAL TRIAL REGISTRATION: 84-02.04.2011.A300.


Subject(s)
Acute Kidney Injury/etiology , Crystalloid Solutions/toxicity , Hydroxyethyl Starch Derivatives/toxicity , Serum Albumin, Human/toxicity , Shock, Septic/therapy , Acute Kidney Injury/physiopathology , Animals , Creatinine/blood , Crystalloid Solutions/therapeutic use , Disease Models, Animal , Drug Administration Schedule , Female , Fluid Therapy/adverse effects , Fluid Therapy/methods , Hemodynamics/physiology , Hydroxyethyl Starch Derivatives/therapeutic use , Norepinephrine/administration & dosage , Oxygen Consumption/physiology , Random Allocation , Serum Albumin, Human/therapeutic use , Sheep, Domestic , Shock, Septic/physiopathology , Vasoconstrictor Agents/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...